Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 49301-49350 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05372445
Microbiome and Health Indicators in People With Obesity, Prediabetes and Type 2 Diabetes Undergoing a Lifestyle Intervention
NARecruiting
480 participants
Started: May 30, 2022 · Completed: Dec 31, 2025
3 conditions6 sponsors1 location
NCT06105242
Biological Sex and CTEPH-related RV Dysfunction and Recovery (BIOSPHeRe)
N/ARecruiting
10 participants
Started: May 30, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05392712
Magnetocardiography in the Accurate Identification of Severe Coronary Lesions and Myocardial Necrosis
NARecruiting
430 participants
Started: May 30, 2022 · Completed: Dec 30, 2024
1 condition14 sponsors1 location
NCT05428514
Evaluating the Impact of Emergency Maternity Housing
NARecruiting
1,048 participants
Started: May 30, 2022 · Completed: Dec 1, 2025
2 conditions6 sponsors1 location
NCT05250843
TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC
PHASE2/PHASE3Recruiting
90 participants
Started: May 30, 2022 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05169866
Nifekalant Versus Amiodarone in New-Onset Atrial Fibrillation After Cardiac Surgery
PHASE3Recruiting
274 participants
Started: May 29, 2022 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT06190860
Platelet Rich Fibrin Treatment for the Alveolar Ridge Preservation in Smokers
NARecruiting
16 participants
Started: May 29, 2022 · Completed: Mar 31, 2024
3 conditions2 sponsors2 locations
NCT05922969
Safety of Low PEEP Maneuvers During ARDS Management
N/ARecruiting
50 participants
Started: May 28, 2022 · Completed: Nov 30, 2024
2 conditions2 sponsors1 location
NCT05521061
The Effect of Human Milk Oligosaccharides in Children With Type 1 Diabetes Mellitus
NARecruiting
111 participants
Started: May 28, 2022 · Completed: Dec 31, 2024
2 conditions3 sponsors1 location
NCT05864170
the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia
EARLY_PHASE1Recruiting
3 participants
Started: May 27, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05397132
Mechanisms of Disease R/R in CAR-T for Hematologic Malignancies
N/ARecruiting
50 participants
Started: May 27, 2022 · Completed: Nov 1, 2026
1 condition3 sponsors1 location
NCT05985525
Microvascular Monitoring in Circulatory Shock and Sepsis (MiMICSS)
N/ARecruiting
100 participants
Started: May 27, 2022 · Completed: May 31, 2026
3 conditions1 sponsor1 location
NCT04988516
Virtual Reality Distraction for Anxiety (VR-IMAGINE)
NARecruiting
98 participants
Started: May 27, 2022 · Completed: May 30, 2025
4 conditions2 sponsors1 location
NCT05265689
Study to Improve Adolescent Bicycling Safety
NARecruiting
195 participants
Started: May 27, 2022 · Completed: Dec 30, 2025
9 conditions2 sponsors1 location
NCT05909878
Virtual Reality Distraction for Anxiety (VR-IMAGINE at HSJ)
NARecruiting
98 participants
Started: May 27, 2022 · Completed: Jun 30, 2025
4 conditions1 sponsor1 location
NCT05199194
Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke
PHASE3Recruiting
398 participants
Started: May 27, 2022 · Completed: Jul 31, 2027
2 conditions4 sponsors13 locations
NCT05168163
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
PHASE2Recruiting
122 participants
Started: May 27, 2022 · Completed: Dec 31, 2026
9 conditions3 sponsors16 locations
NCT05290246
TRE in Type 2 Diabetes (See Food Study 3)
NARecruiting
60 participants
Started: May 27, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05451303
Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
N/ARecruiting
475 participants
Started: May 27, 2022 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT05452291
Multiomics Biomarkers for Urolithiasis
N/ARecruiting
1,200 participants
Started: May 27, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05389293
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
PHASE2Recruiting
152 participants
Started: May 27, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor9 locations
NCT05270525
Effect of Ensifentrine on Sputum Markers of Inflammation in COPD
PHASE2Recruiting
50 participants
Started: May 27, 2022 · Completed: Jun 30, 2027
1 condition2 sponsors2 locations
NCT04890938
Sputum-guided Treatment With Comprehensive Care Management in COPD - A Randomized-controlled Trial
NARecruiting
128 participants
Started: May 27, 2022 · Completed: Aug 31, 2025
1 condition4 sponsors2 locations
NCT05041127
Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma
PHASE2Recruiting
15 participants
Started: May 27, 2022 · Completed: Sep 1, 2026
3 conditions1 sponsor1 location
NCT05338541
Tucidinostat Plus Etoposide in the Treatment of Neuroblastoma in Childhood.
PHASE1Recruiting
30 participants
Started: May 27, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04538573
Virtual Reality MObility for Burn Patients
NARecruiting
20 participants
Started: May 27, 2022 · Completed: May 30, 2024
1 condition1 sponsor1 location
NCT05780359
Evaluating the Safety and Efficacy of the G-stream® Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery
NARecruiting
280 participants
Started: May 27, 2022 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT05034432
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
PHASE4Recruiting
100 participants
Started: May 27, 2022 · Completed: Jun 30, 2026
2 conditions2 sponsors19 locations
NCT05008159
A Community-based Program That Supports Physical Activity, Healthy Eating, Social Participation and System Navigation in Older Adults
NARecruiting
500 participants
Started: May 27, 2022 · Completed: Mar 31, 2025
4 conditions4 sponsors2 locations
NCT06418087
Durvalumab With Carboplatin and Etoposide Chemotherapy in Pulmonary Large-cell Neuroendocrine Carcinoma (LCNEC)
PHASE2Recruiting
49 participants
Started: May 27, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor15 locations
NCT05448625
Genoss DES in Patients With a High Risk of Ischemic Events (GENTLE Registry)
N/ARecruiting
200 participants
Started: May 26, 2022 · Completed: Dec 31, 2026
2 conditions3 sponsors1 location
NCT05056597
Incentive Processing and Learning in Anorexia Nervosa and Bulimia Nervosa
N/ARecruiting
252 participants
Started: May 26, 2022 · Completed: Jan 31, 2027
2 conditions1 sponsor1 location
NCT05139498
Conservative Management for PAS Pilot
NARecruiting
32 participants
Started: May 26, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05405582
"Thetha Nami Ngithethe Nawe (Let's Talk): Step Wedge cRCT of Peer Led Community PrEP and SRH for Youth in South Africa"
NARecruiting
6,000 participants
Started: May 26, 2022 · Completed: May 1, 2025
2 conditions1 sponsor1 location
NCT05486013
Zanubrutinib in the Treatment of Recurrent Refractory Mantle Cell Lymphoma
N/ARecruiting
30 participants
Started: May 26, 2022 · Completed: Nov 26, 2025
1 condition6 sponsors1 location
NCT05297552
A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer
PHASE2Recruiting
40 participants
Started: May 26, 2022 · Completed: Feb 28, 2025
1 condition1 sponsor3 locations
NCT05170412
Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
N/ARecruiting
80 participants
Started: May 26, 2022 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT06237400
A Study of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors.
PHASE1/PHASE2Recruiting
110 participants
Started: May 26, 2022 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT05298124
Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock
NARecruiting
144 participants
Started: May 26, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor4 locations
NCT05147792
The CONFORM Pivotal Trial
NARecruiting
1,600 participants
Started: May 26, 2022 · Completed: Dec 31, 2031
2 conditions1 sponsor70 locations
NCT05262439
Post Market Clinical Follow Up of ResMed Mask Systems
NARecruiting
500 participants
Started: May 26, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT05487612
MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)
NARecruiting
1,300 participants
Started: May 26, 2022 · Completed: Mar 31, 2027
3 conditions2 sponsors12 locations
NCT05366868
Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus
PHASE4Recruiting
567 participants
Started: May 26, 2022 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT05449067
Comparison of Efficacy Between Nighttime and Daytime Peritoneal Dialysis
NARecruiting
124 participants
Started: May 26, 2022 · Completed: Dec 30, 2025
2 conditions15 sponsors1 location
NCT05327933
Preventing Recurrences of Chronic Subdural Hematoma in Adult Patients by Middle Meningeal Artery Embolization
NARecruiting
154 participants
Started: May 26, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05317494
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Greece
N/ARecruiting
100 participants
Started: May 26, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor13 locations
NCT05412680
Transoral Endoscopic Thyroidectomy by Vestibular Approach (TOETVA)
NARecruiting
60 participants
Started: May 25, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT04863950
Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
PHASE2Recruiting
25 participants
Started: May 25, 2022 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT05301764
A Study of LVGN6051 Combined with Anlotinib in Patient with Soft Tissue Sarcoma
PHASE1/PHASE2Recruiting
65 participants
Started: May 25, 2022 · Completed: Oct 19, 2025
1 condition1 sponsor5 locations
NCT05307289
Study of Alterations in Tumor Metabolism Associated With the Development of Immunotherapy Resistance in Melanoma
NARecruiting
20 participants
Started: May 25, 2022 · Completed: Oct 25, 2028
1 condition1 sponsor1 location